ReferencesBrunner, L.S. & Suddarth, D,.S,., The Lippincott Manual of Nursing Practice. JB Lippincott, 1999 Hermann Is Melander A: Biguanides: Basic aspects and Clinical use. In International Textbook of Diabetes Mellitus. Simmer PZ, Alberti KGMM, DeFronzo RA, Keen H, Eds, New York, John Wiley and sons, 1992. Norwitz, B.E., Adkisson, S. editors. Clinical Nursing Diabetic Ketoacidosis. C.V. Mosby Co., 1986. Kassane, J.M., MD., Editor: Anderson’s Pathology: Diabetes. C.V. Mosby Co., 1985. Armstrong DG, Lavery LA, Harkless LB. “Validatin of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation”, Diabetes Care. 1994. Schneider SH, Rudderman NB. “Exercise and NIDDM”, Diabetes Care, 1990. Wasserman DH, Zinman B: Exercise in individuals with IDDM, Diabetes Care. 1994. Karam JH. “Diabetes Mellitus, hypoglycemia & lipoprotein disorders”, In Schroeder SA, Krupp MA, Tierney LM Jr. McPhee SI, editors, Current Medical Diagnosis and Treatment. 1991. Norwalk and San Mateo: Appleton & Lange, 1991. Wallach, Jacques, Handbook of Interpretation of Diagnostic Tests. Lippincott-Raven publishers, Philadelphia, 1998. Dunn CJ, Peters DH: Metformin. “A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus”, Drugs 49:721-49, 1995. Calle-Pascual al, Garcia-Honduvillea J, Martin-Alvarez PJ, Vara E, Calle JR, Munguira ME, Maranes JP. “Comparison between Acarbose, Metformin, and insulin treatment in Type 2 diabetic patients with secondary failure to sulfonylurea treatment” Diabete Metab 21:256-60, 1995. Edelman S. “Troglitazone: a new and unique oral anti-diabetic agent for the treatment of type II diabetes and the insulin resistance syndrome””, Clinical Diabetes 15:60-65 1997. Kumar S, Boulton AJM, Beck-Neilsen H, Berthezene F, Muggeo Mm, Persson B, Spinas GA, Donoghe S, Lettis s, Stewart-Long P. “Troglitazone, an insulin action enhancer improves metabolic control in NIDDM patients”, Diabetologia 39: 701-709, 1996. Diabetes/Metabolism Reviews. Volume 14, issue 4, John Wiley and Sons, LTD, 1998. Boulton AJM. “Current and emerging treatments of the diabetic neuropathies”, Diabetes Rev 7:379-386, 1999 Eaton S, Tesfaye S. “Clinical manifestations and measurement f somatic neuropathy”, Diabetes Rev 7:312-325, 1999 Next Course Exam |